The latest research study released by Market IntelliX evaluates market size and forecasts of Cold Sore Treatment in Global, including the following market information:
Global Cold Sore Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cold Sore Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antiviral Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cold Sore Treatment include GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex and Aurobindo Pharma USA, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Cold Sore Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Cold Sore Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cold Sore Treatment Market Segment Percentages, by Type, 2021 (%)
Antiviral Agents
Analgesic Agents
Others
Global Cold Sore Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cold Sore Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
Global Cold Sore Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cold Sore Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cold Sore Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cold Sore Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
GlaxoSmithKline
Ortho Dermatologics
Foundation Consumer Healthcare
Novartis
Teva Pharmaceuticals
Amneal Pharmaceuticals LLC
AiCuris
Apotex
Aurobindo Pharma USA, Inc.
Cipla
Glenmark Pharmaceuticals, Inc.
Hikma Pharmaceuticals
HRA Pharma
Hetero Healthcare Ltd
Jubilant Cadista
Merix Pharmaceutical Corp
Square
Sun Pharmaceutical Industries Ltd.
Viatris
Wockhardt
Zydus Pharmaceuticals
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Cold Sore Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cold Sore Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cold Sore Treatment Overall Market Size
2.1 Global Cold Sore Treatment Market Size: 2021 VS 2028
2.2 Global Cold Sore Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cold Sore Treatment Players in Global Market
3.2 Top Global Cold Sore Treatment Companies Ranked by Revenue
3.3 Global Cold Sore Treatment Revenue by Companies
3.4 Top 3 and Top 5 Cold Sore Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cold Sore Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cold Sore Treatment Players in Global Market
3.6.1 List of Global Tier 1 Cold Sore Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Cold Sore Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cold Sore Treatment Market Size Markets, 2021 & 2028
4.1.2 Antiviral Agents
4.1.3 Analgesic Agents
4.1.4 Others
4.2 By Type - Global Cold Sore Treatment Revenue & Forecasts
4.2.1 By Type - Global Cold Sore Treatment Revenue, 2017-2022
4.2.2 By Type - Global Cold Sore Treatment Revenue, 2023-2028
4.2.3 By Type - Global Cold Sore Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cold Sore Treatment Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Cold Sore Treatment Revenue & Forecasts
5.2.1 By Application - Global Cold Sore Treatment Revenue, 2017-2022
5.2.2 By Application - Global Cold Sore Treatment Revenue, 2023-2028
5.2.3 By Application - Global Cold Sore Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cold Sore Treatment Market Size, 2021 & 2028
6.2 By Region - Global Cold Sore Treatment Revenue & Forecasts
6.2.1 By Region - Global Cold Sore Treatment Revenue, 2017-2022
6.2.2 By Region - Global Cold Sore Treatment Revenue, 2023-2028
6.2.3 By Region - Global Cold Sore Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cold Sore Treatment Revenue, 2017-2028
6.3.2 US Cold Sore Treatment Market Size, 2017-2028
6.3.3 Canada Cold Sore Treatment Market Size, 2017-2028
6.3.4 Mexico Cold Sore Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cold Sore Treatment Revenue, 2017-2028
6.4.2 Germany Cold Sore Treatment Market Size, 2017-2028
6.4.3 France Cold Sore Treatment Market Size, 2017-2028
6.4.4 U.K. Cold Sore Treatment Market Size, 2017-2028
6.4.5 Italy Cold Sore Treatment Market Size, 2017-2028
6.4.6 Russia Cold Sore Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Cold Sore Treatment Market Size, 2017-2028
6.4.8 Benelux Cold Sore Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cold Sore Treatment Revenue, 2017-2028
6.5.2 China Cold Sore Treatment Market Size, 2017-2028
6.5.3 Japan Cold Sore Treatment Market Size, 2017-2028
6.5.4 South Korea Cold Sore Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Cold Sore Treatment Market Size, 2017-2028
6.5.6 India Cold Sore Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cold Sore Treatment Revenue, 2017-2028
6.6.2 Brazil Cold Sore Treatment Market Size, 2017-2028
6.6.3 Argentina Cold Sore Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cold Sore Treatment Revenue, 2017-2028
6.7.2 Turkey Cold Sore Treatment Market Size, 2017-2028
6.7.3 Israel Cold Sore Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Cold Sore Treatment Market Size, 2017-2028
6.7.5 UAE Cold Sore Treatment Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cold Sore Treatment Major Product Offerings
7.1.4 GlaxoSmithKline Cold Sore Treatment Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Ortho Dermatologics
7.2.1 Ortho Dermatologics Corporate Summary
7.2.2 Ortho Dermatologics Business Overview
7.2.3 Ortho Dermatologics Cold Sore Treatment Major Product Offerings
7.2.4 Ortho Dermatologics Cold Sore Treatment Revenue in Global Market (2017-2022)
7.2.5 Ortho Dermatologics Key News
7.3 Foundation Consumer Healthcare
7.3.1 Foundation Consumer Healthcare Corporate Summary
7.3.2 Foundation Consumer Healthcare Business Overview
7.3.3 Foundation Consumer Healthcare Cold Sore Treatment Major Product Offerings
7.3.4 Foundation Consumer Healthcare Cold Sore Treatment Revenue in Global Market (2017-2022)
7.3.5 Foundation Consumer Healthcare Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Cold Sore Treatment Major Product Offerings
7.4.4 Novartis Cold Sore Treatment Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Corporate Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Cold Sore Treatment Major Product Offerings
7.5.4 Teva Pharmaceuticals Cold Sore Treatment Revenue in Global Market (2017-2022)
7.5.5 Teva Pharmaceuticals Key News
7.6 Amneal Pharmaceuticals LLC
7.6.1 Amneal Pharmaceuticals LLC Corporate Summary
7.6.2 Amneal Pharmaceuticals LLC Business Overview
7.6.3 Amneal Pharmaceuticals LLC Cold Sore Treatment Major Product Offerings
7.6.4 Amneal Pharmaceuticals LLC Cold Sore Treatment Revenue in Global Market (2017-2022)
7.6.5 Amneal Pharmaceuticals LLC Key News
7.7 AiCuris
7.7.1 AiCuris Corporate Summary
7.7.2 AiCuris Business Overview
7.7.3 AiCuris Cold Sore Treatment Major Product Offerings
7.7.4 AiCuris Cold Sore Treatment Revenue in Global Market (2017-2022)
7.7.5 AiCuris Key News
7.8 Apotex
7.8.1 Apotex Corporate Summary
7.8.2 Apotex Business Overview
7.8.3 Apotex Cold Sore Treatment Major Product Offerings
7.8.4 Apotex Cold Sore Treatment Revenue in Global Market (2017-2022)
7.8.5 Apotex Key News
7.9 Aurobindo Pharma USA, Inc.
7.9.1 Aurobindo Pharma USA, Inc. Corporate Summary
7.9.2 Aurobindo Pharma USA, Inc. Business Overview
7.9.3 Aurobindo Pharma USA, Inc. Cold Sore Treatment Major Product Offerings
7.9.4 Aurobindo Pharma USA, Inc. Cold Sore Treatment Revenue in Global Market (2017-2022)
7.9.5 Aurobindo Pharma USA, Inc. Key News
7.10 Cipla
7.10.1 Cipla Corporate Summary
7.10.2 Cipla Business Overview
7.10.3 Cipla Cold Sore Treatment Major Product Offerings
7.10.4 Cipla Cold Sore Treatment Revenue in Global Market (2017-2022)
7.10.5 Cipla Key News
7.11 Glenmark Pharmaceuticals, Inc.
7.11.1 Glenmark Pharmaceuticals, Inc. Corporate Summary
7.11.2 Glenmark Pharmaceuticals, Inc. Business Overview
7.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Major Product Offerings
7.11.4 Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Revenue in Global Market (2017-2022)
7.11.5 Glenmark Pharmaceuticals, Inc. Key News
7.12 Hikma Pharmaceuticals
7.12.1 Hikma Pharmaceuticals Corporate Summary
7.12.2 Hikma Pharmaceuticals Business Overview
7.12.3 Hikma Pharmaceuticals Cold Sore Treatment Major Product Offerings
7.12.4 Hikma Pharmaceuticals Cold Sore Treatment Revenue in Global Market (2017-2022)
7.12.5 Hikma Pharmaceuticals Key News
7.13 HRA Pharma
7.13.1 HRA Pharma Corporate Summary
7.13.2 HRA Pharma Business Overview
7.13.3 HRA Pharma Cold Sore Treatment Major Product Offerings
7.13.4 HRA Pharma Cold Sore Treatment Revenue in Global Market (2017-2022)
7.13.5 HRA Pharma Key News
7.14 Hetero Healthcare Ltd
7.14.1 Hetero Healthcare Ltd Corporate Summary
7.14.2 Hetero Healthcare Ltd Business Overview
7.14.3 Hetero Healthcare Ltd Cold Sore Treatment Major Product Offerings
7.14.4 Hetero Healthcare Ltd Cold Sore Treatment Revenue in Global Market (2017-2022)
7.14.5 Hetero Healthcare Ltd Key News
7.15 Jubilant Cadista
7.15.1 Jubilant Cadista Corporate Summary
7.15.2 Jubilant Cadista Business Overview
7.15.3 Jubilant Cadista Cold Sore Treatment Major Product Offerings
7.15.4 Jubilant Cadista Cold Sore Treatment Revenue in Global Market (2017-2022)
7.15.5 Jubilant Cadista Key News
7.16 Merix Pharmaceutical Corp
7.16.1 Merix Pharmaceutical Corp Corporate Summary
7.16.2 Merix Pharmaceutical Corp Business Overview
7.16.3 Merix Pharmaceutical Corp Cold Sore Treatment Major Product Offerings
7.16.4 Merix Pharmaceutical Corp Cold Sore Treatment Revenue in Global Market (2017-2022)
7.16.5 Merix Pharmaceutical Corp Key News
7.17 Square
7.17.1 Square Corporate Summary
7.17.2 Square Business Overview
7.17.3 Square Cold Sore Treatment Major Product Offerings
7.17.4 Square Cold Sore Treatment Revenue in Global Market (2017-2022)
7.17.5 Square Key News
7.18 Sun Pharmaceutical Industries Ltd.
7.18.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
7.18.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.18.3 Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Major Product Offerings
7.18.4 Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Revenue in Global Market (2017-2022)
7.18.5 Sun Pharmaceutical Industries Ltd. Key News
7.19 Viatris
7.19.1 Viatris Corporate Summary
7.19.2 Viatris Business Overview
7.19.3 Viatris Cold Sore Treatment Major Product Offerings
7.19.4 Viatris Cold Sore Treatment Revenue in Global Market (2017-2022)
7.19.5 Viatris Key News
7.20 Wockhardt
7.20.1 Wockhardt Corporate Summary
7.20.2 Wockhardt Business Overview
7.20.3 Wockhardt Cold Sore Treatment Major Product Offerings
7.20.4 Wockhardt Cold Sore Treatment Revenue in Global Market (2017-2022)
7.20.5 Wockhardt Key News
7.21 Zydus Pharmaceuticals
7.21.1 Zydus Pharmaceuticals Corporate Summary
7.21.2 Zydus Pharmaceuticals Business Overview
7.21.3 Zydus Pharmaceuticals Cold Sore Treatment Major Product Offerings
7.21.4 Zydus Pharmaceuticals Cold Sore Treatment Revenue in Global Market (2017-2022)
7.21.5 Zydus Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cold Sore Treatment Market Opportunities & Trends in Global Market
Table 2. Cold Sore Treatment Market Drivers in Global Market
Table 3. Cold Sore Treatment Market Restraints in Global Market
Table 4. Key Players of Cold Sore Treatment in Global Market
Table 5. Top Cold Sore Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cold Sore Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cold Sore Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cold Sore Treatment Product Type
Table 9. List of Global Tier 1 Cold Sore Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cold Sore Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cold Sore Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cold Sore Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cold Sore Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cold Sore Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cold Sore Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cold Sore Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cold Sore Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cold Sore Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cold Sore Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cold Sore Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cold Sore Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cold Sore Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cold Sore Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cold Sore Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cold Sore Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cold Sore Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cold Sore Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cold Sore Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cold Sore Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Cold Sore Treatment Product Offerings
Table 32. GlaxoSmithKline Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Ortho Dermatologics Corporate Summary
Table 34. Ortho Dermatologics Cold Sore Treatment Product Offerings
Table 35. Ortho Dermatologics Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Foundation Consumer Healthcare Corporate Summary
Table 37. Foundation Consumer Healthcare Cold Sore Treatment Product Offerings
Table 38. Foundation Consumer Healthcare Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Cold Sore Treatment Product Offerings
Table 41. Novartis Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceuticals Corporate Summary
Table 43. Teva Pharmaceuticals Cold Sore Treatment Product Offerings
Table 44. Teva Pharmaceuticals Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Amneal Pharmaceuticals LLC Corporate Summary
Table 46. Amneal Pharmaceuticals LLC Cold Sore Treatment Product Offerings
Table 47. Amneal Pharmaceuticals LLC Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AiCuris Corporate Summary
Table 49. AiCuris Cold Sore Treatment Product Offerings
Table 50. AiCuris Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Apotex Corporate Summary
Table 52. Apotex Cold Sore Treatment Product Offerings
Table 53. Apotex Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Aurobindo Pharma USA, Inc. Corporate Summary
Table 55. Aurobindo Pharma USA, Inc. Cold Sore Treatment Product Offerings
Table 56. Aurobindo Pharma USA, Inc. Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Cipla Corporate Summary
Table 58. Cipla Cold Sore Treatment Product Offerings
Table 59. Cipla Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Glenmark Pharmaceuticals, Inc. Corporate Summary
Table 61. Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Product Offerings
Table 62. Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Hikma Pharmaceuticals Corporate Summary
Table 64. Hikma Pharmaceuticals Cold Sore Treatment Product Offerings
Table 65. Hikma Pharmaceuticals Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 66. HRA Pharma Corporate Summary
Table 67. HRA Pharma Cold Sore Treatment Product Offerings
Table 68. HRA Pharma Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Hetero Healthcare Ltd Corporate Summary
Table 70. Hetero Healthcare Ltd Cold Sore Treatment Product Offerings
Table 71. Hetero Healthcare Ltd Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Jubilant Cadista Corporate Summary
Table 73. Jubilant Cadista Cold Sore Treatment Product Offerings
Table 74. Jubilant Cadista Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Merix Pharmaceutical Corp Corporate Summary
Table 76. Merix Pharmaceutical Corp Cold Sore Treatment Product Offerings
Table 77. Merix Pharmaceutical Corp Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Square Corporate Summary
Table 79. Square Cold Sore Treatment Product Offerings
Table 80. Square Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 82. Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Product Offerings
Table 83. Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Viatris Corporate Summary
Table 85. Viatris Cold Sore Treatment Product Offerings
Table 86. Viatris Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Wockhardt Corporate Summary
Table 88. Wockhardt Cold Sore Treatment Product Offerings
Table 89. Wockhardt Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
Table 90. Zydus Pharmaceuticals Corporate Summary
Table 91. Zydus Pharmaceuticals Cold Sore Treatment Product Offerings
Table 92. Zydus Pharmaceuticals Cold Sore Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cold Sore Treatment Segment by Type in 2021
Figure 2. Cold Sore Treatment Segment by Application in 2021
Figure 3. Global Cold Sore Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cold Sore Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cold Sore Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cold Sore Treatment Revenue in 2021
Figure 8. By Type - Global Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 12. US Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 24. China Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cold Sore Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cold Sore Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ortho Dermatologics Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Foundation Consumer Healthcare Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceuticals Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amneal Pharmaceuticals LLC Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AiCuris Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Apotex Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Aurobindo Pharma USA, Inc. Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cipla Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hikma Pharmaceuticals Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. HRA Pharma Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hetero Healthcare Ltd Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Jubilant Cadista Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Merix Pharmaceutical Corp Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Square Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Viatris Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Wockhardt Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Zydus Pharmaceuticals Cold Sore Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|